Enanta Pharmaceuticals reported $-33024000 in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Amgen AMGN:US $ 3228M 40M
Anika Therapeutics ANIK:US $ 6.33M 8.56M
Arrowhead Research ARWR:US $ -62379000 32.51M
AstraZeneca AZN:LN 2784M 588M
Biogen BIIB:US $ 991.8M 155.8M
Bristol Myers Squibb BMY:US $ 5712M 33M
Clovis Oncology CLVS:US $ -52.17M 0.97M
Gilead Sciences GILD:US $ 4370M 1605M
GlaxoSmithKline GSK:LN 3660M 1034M
Halozyme Therapeutics HALO:US $ 76.34M 17.51M
Insmed INSM:US $ -91545000 6.9M
Intercept Pharmaceuticals ICPT:US $ -5.41M 6.8M
Johnson & Johnson JNJ:US $ 8192M 2043M
Karyopharm Therapeutics KPTI:US $ -43626000 5.19M
Ligand Pharmaceuticals LGND:US $ 28.43M 29.92M
Marinus Pharmaceuticals MRNS:US $ -19.08M 4.32M
Neurocrine Biosciences NBIX:US $ 47.3M 23.1M
Novartis NOVN:VX SF 4837M 65M
Novavax NVAX:US $ -302.88M 40.54M
Pfizer PFE:US $ 10235M 2245M
Ptc Therapeutics PTCT:US $ -76.33M 7.18M
Sarepta Therapeutics SRPT:US $ -23.96M 135.16M
Vertex Pharmaceuticals VRTX:US $ 1087.41M 1092.53M
YTE INCY:US $ 262.16M 92.39M